Prazosin-d8

• CAT Number: S000115
• CAS Number: 1006717-55-0
• Molecular Formula: C19H13D8N5O4
• Molecular Weight: 391.45
• Purity: ≥95%
• Target: Neuronal Signaling
• IUPAC Name: [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-2,2,3,3,5,5,6,6-octadeuteriopiperazin-1-yl]-(furan-2-yl)methanone
• InChI: InChI=1S/C19H21N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h3-4,9-11H,5-8H2,1-2H3,(H2,20,21,22)/i5D2,6D2,7D2,8D2
• InChIKey: IENZQIKPVFGBNW-YEBVBAJPSA-N
• SMILES: [2H]C1(C(N(C(C(N1C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC)([2H])[2H])([2H])[2H])C(=O)C4=CC=CO4)([2H])[2H])[2H]

Prazosin-d8 (CAS: 1006717-55-0), a high-quality pharmaceutical research compound designed for advanced studies in cardiovascular and antihypertensive research. As a deuterated analog of Prazosin, it offers enhanced stability and improved pharmacokinetic properties. Prazosin-d8 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies for hypertension and related cardiovascular conditions. Trusted by leading laboratories, Prazosin-d8 is your go-to solution for cutting-edge cardiovascular research. Unlock new possibilities in hypertension treatment with Prazosin-d8, where innovation meets reliability.